Skip to main content

Table 3 Resistance profiles of major Gram-negative bacteria from 27 VAP patients in a public hospital of northern Brazil

From: Epidemiology and outcomes of ventilator-associated pneumonia in northern Brazil: an analytical descriptive prospective cohort study

Microorganism

N

Antibioticsa/No. of resistant strains (%)

PIP

FEP

ATM

CAZ

CIP

MEM

GEN

IPM

TZP

TOB

AMK

P. aeruginosa

11

5 (45.4)

6 (54.5)

4 (36.4)

6 (54.5)

5 (45.4)

5 (45.4)

4 (36.4)

5 (45.4)

4 (36.4)

4 (36.4)

2 (18.2)

Acinetobacter spp.

11

7 (63.6)

7 (63.6)

8 (72.7)

7 (63.6)

7 (63.6)

7 (63.6)

5 (45.4)

6 (54.5)

5 (45.4)

2 (18.2)

3 (27.3)

Enterobacteriaceaeb

8

7 (87.5)

3 (37.5)

3 (37.5)

2 (25.0)

3 (37.5)

1 (12,5)

4 (50.0)

1 (12,5)

1 (12,5)

4 (50.0)

1 (12,5)

Total

30

19 (63.3)

16 (53.3)

15 (50.0)

15 (50.0)

15 (50.0)

13 (43.3)

13 (43.3)

12 (40.0)

10 (33.3)

10 (33.3)

6 (20.0)

  1. a PIP: Piperacillin; ATM: Aztreonam; FEP: Cefepime; CAZ: Ceftazidime; CIP: Ciprofloxacin; MEM: Meropenem; GEN: Gentamicin; IPM: Imipenem; TZP: Piperacillin/Tazobactam; TOB: Tobramycin; AMK: Amikacin. b Klebsiella (5), Enterobacter (2), and Escherichia (1).